Press Room

Article / Jan 17, 2005

Custom Chemicals

C&EN, 17 January 2005

Custom synthesis providers greet new year with cautious optimism, focusing on innovation as a key component of success in a hypercompetitive business climate.

Read the full article at C&EN website


Also in the Press Room

Press Release / Mar 07, 2018

Hovione sells the iMAX business

Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.